Anxiety and anxiety disorders are thought to be associated with many different neurological diseases, including epilepsy, multiple sclerosis, and Parkinson’s disease.1-6
References:
1.Tuft M, Henning O, Nakken KO. Epilepsy and anxiety. Tidsskr Nor Laegeforen 2018; 138 (17).
2.Jansen C, Francomme L, Vignal JP, et al. Interictal psychiatric comorbidities of drug-resistant focal epilepsy: prevalence and influence of the localization of the epilepsy. Epilepsy Behav 2019; 94: 288–296.
3.Marrie RA, Patel R, Figley CR, et al.; Comorbidity and Cognition in Multiple Sclerosis (CCOMS) Study Group. Diabetes and anxiety adversely affect cognition in multiple sclerosis. Mult Scler Relat Disord 2019; 27: 164–170.
4.Whitehouse CE, Fisk JD, Bernstein CN, et al.; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease. Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders. Neurology 2019; 92 (5): e406–e417.
5.Smeltere L, Kuzņecovs V, Erts R. Depression and social phobia in essential tremor and Parkinson’s disease. Brain Behav 2017; 7 (9): e00781.
6.Rana AQ, Ansari H, Qureshi ARM, Rahman E. Impact of progression of Parkinson’s disease and various other factors on generalized anxiety disorder. J Neurosci Rural Pract 2018; 9 (3): 287–290.
